Tonix Pharmaceuticals Holding (TNXP) Operating Expenses (2011 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Operating Expenses of $48.4 million for Q1 2026, up 161.94% year-over-year from $18.5 million in Q1 2025, and down 9.8% quarter-over-quarter from $53.7 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Operating Expenses (2011 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Operating Expenses history runs 16 years deep, the most recent figure standing at $48.4 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 161.94% year-over-year to $48.4 million; the TTM figure through Mar 2026 stood at $168.7 million (up 19.3% YoY), while the FY2025 annual figure was $138.8 million, down 5.44% from the prior year.
- Operating Expenses for Q1 2026 stood at $48.4 million, down from $53.7 million in the prior quarter.
- The five-year high for Operating Expenses was $79.5 million in Q2 2024, with the low at $18.4 million in Q3 2024.
- The 5-year median for Operating Expenses is $30.3 million (2025), against an average of $33.7 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses soared 174.2% in 2024, then slumped 61.91% in 2025.
- Tonix Pharmaceuticals Holding's Operating Expenses stood at $32.7 million in 2022, then dropped by 4.95% to $31.1 million in 2023, then decreased by 19.44% to $25.1 million in 2024, then soared by 114.17% to $53.7 million in 2025, then declined by 9.8% to $48.4 million in 2026.
- Business Quant data shows TNXP's Operating Expenses at $48.4 million in Q1 2026, $53.7 million in Q4 2025, and $36.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 56.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.08 Mn |
| Mar 31, 2026 | 48.42 Mn |
| Dec 31, 2025 | 53.68 Mn |
| Sep 30, 2025 | 36.36 Mn |
| Jun 30, 2025 | 30.29 Mn |
| Mar 31, 2025 | 18.48 Mn |
| Dec 31, 2024 | 25.06 Mn |
| Sep 30, 2024 | 18.38 Mn |
| Jun 30, 2024 | 79.52 Mn |
| Mar 31, 2024 | 23.83 Mn |
| Dec 31, 2023 | 31.11 Mn |
| Sep 30, 2023 | 32.14 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 33.90 Mn |
| Dec 31, 2022 | 32.73 Mn |
| Sep 30, 2022 | 29.59 Mn |
| Jun 30, 2022 | 23.34 Mn |
| Mar 31, 2022 | 26.44 Mn |
| Dec 31, 2021 | 29.48 Mn |
| Sep 30, 2021 | 18.54 Mn |